New podcast season to spotlight P&L-focused leaders blazing the trail to purposeful procurement ...

Q4 2025 earnings call recap: pipeline milestones, PROTAC FDA/PDUFA timeline, 2026 data catalysts, and cash runway—read now.

According to data from Fiscal AI, Novavax is expected to report a quarterly loss per share of $0.55, higher than the loss of ...

Explore Pfizer’s evolving pipeline strategy, expanding into oncology and obesity to drive growth beyond its COVID-19 success.

In this role, Dr. Lewis-Hall will guide clinical development strategy, regulatory engagement, and translational rigor across Helus’ novel ...

Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind Biosciences") today announced a strategic commercialization collaboration with Pfizer China for Ecnoglutide injection (Ecnoglutide), a new--generation ...

Agreement worth up to $495 million is part of a growing number of Chinese deals with global pharma giants as the country ...

Xbox chief Phil Spencer is leaving Microsoft after nearly 40 years at the software giant. Xbox president Sarah Bond is also ...

Olema Pharmaceuticals, Inc. ( OLMA) Citi's 2026 Virtual Oncology Leadership Summit February 19, 2026 1:00 PM EST ...

Seasoned Life Sciences Executive Joins to Lead Operations and Scale Lahjavida’s Dye-Drug Conjugate Platform COLORADO ...

Liam Dunne is Co-founder and CEO of Klearcom, an Irish SaaS company that helps global brands monitor and improve IVR and ...

After an FDA rejection of its spinocerebellar ataxia (SCA) therapy, Biohaven was forced to rethink its strategy—cutting R&D spend by 60% and channeling the spirit of a scrappy startup again as it ...